Myriad Genetics (MYGN) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $4.60 +1.32%
Revenue Growth %: -2.7%
Financial Fact:
Income tax provision (benefit): 5.2M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -2.7%
Financial Fact:
Income tax provision (benefit): 5.2M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q2 EPS of $0.26, $0.02 better than the analyst estimate of $0.24. Revenue for the quarter came in at $196.5 million versus the consensus estimate of $189.72 million.
GUIDANCE:
Myriad Genetics sees Q3 2017 EPS of $0.23-$0.25, versus the consensus of $0.25.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Playboy to buy back 16.6M shares from Fortress at $1.05 each
- Tutor Perini launches $400M senior notes offering due 2033
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
